Please Wait.....
Report
North America Benign Prostatic Hyperplasic Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product (Resectoscopes, Urology Laser, Radiofrequency Ablation Devices, Prostatic Stents, and Implants), Procedure Type (Transurethral Microwave Therapy, Transurethral Resection of the Prostate, Transurethral Needle Ablation of the Prostate, Laser Surgery, Urolift Surgery, and Others), and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)
Market Report I 2022-10-14 I 146 Pages I The Insight Partners
The benign prostatic hyperplasic devices market in North America is expected to grow from US$ 863.12 million in 2022 to US$ 1,349.19 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2022 to 2028.
Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate. This noncancerous prostate condition is usually not fatal. Being benign, the condition does not involve metastasis to other body parts. BPH is not associated with the risk of prostate cancer; moreover, unless it manifests symptoms, BPH isn't considered a health issue. Almost all men are likely to have some prostate growth by the time they turn 70. Aging, abdominal obesity, and insufficient physical exercise raise the risk of developing BPH. According to the National Center for Biotechnology Information (NCBI), BPH is one of the most common disorders in older men and the leading cause of lower urinary tract symptoms (LUTS). After the age of 40, the prevalence of BPH rises, reaching a peak of 60% by the age of 90. Many autopsy studies suggest that the histological prevalence of BPH is 8%, 50%, and 80% in the fourth, sixth, and ninth decades of the life of a man, respectively. Old age has also been shown to be a risk factor for the onset and progression of clinical BPH in observational studies conducted in the US. According to statistics from the Krimpen and Baltimore Longitudinal Study of Aging, the prostate grows at a rate of 2.0-2.5% per year in elderly men. Continued prostate enlargement may develop into LUTS, and larger prostates are associated with a benign prostatic enlargement (BPE), which triggers the risk of developing clinical BPH and urine incontinence. According to the NCBI data, increased adiposity is found to have a positive correlation with prostate volume. In numerous study groups, body weight, body mass index (BMI), and waist circumference have been seen to have a positive correlation with prostate volume. Additionally, epidemiological data shows obesity may raise the need for BPH surgery and BPH treatment.
According to the American Journal of Men's Health (AJMH), in 2019, globally, there were 11.26 million new cases and 1.86 million YLD due to BPH in 2019. The incidence of BPH increased by 105.7%, and YLD increased by 110.6% worldwide during 1990-2019. The absolute incidence and YLD numbers increased considerably worldwide during this period, primarily, due to population increase and aging. The treatment option for BPH includes surgeries such as transurethral resection of the prostate (TURP), open prostatectomy, and minimally invasive treatments such as transurethral needle ablation (TUNA). Benign prostatic hyperplasic devices are used in minimally invasive treatments such as radiofrequency ablation, laser therapy, and implants. Thus, the increase in the prevalence of benign prostatic hyperplasia and related risk factors bolsters the demand for benign prostatic hyperplasic devices.
North America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
North America Benign Prostatic Hyperplasic Devices Market Segmentation
The North America benign prostatic hyperplasic devices market is segmented on the basis of product, procedure type, end user, and country. Based on product, the market is segmented into resectoscopes, urology lasers, radiofrequency ablation devices, prostatic stents, and implants. The resectoscopes segment is expected to hold the largest share of the market in 2022. On the other hand, the urology lasers segment is expected to register the highest CAGR during the forecast period. Based on procedure type, the North America benign prostatic hyperplasic devices market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. The transurethral resection of the prostate segment held the largest market share in 2022, and it is also expected to register the highest CAGR in the market during the forecast period. Based on end user, the North America benign prostatic hyperplasic devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2022, while the clinics segment is expected to register the highest CAGR during the forecast period. Based on country, the North America benign prostatic hyperplasic devices market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share, and it is further expected to register the highest CAGR during the forecast period.
KARL STORZ SE & Co. KG; Olympus Corporation; Boston Scientific Corporation; Teleflex Incorporated; Richard Wolf GmbH; Urologix, LLC; OmniGuide Holdings, Inc.; and Convergent Laser Technologies are among the leading companies in the North America benign prostatic hyperplasic devices market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Benign Prostatic Hyperplasic Devices Market - By Product
1.3.2 North America Benign Prostatic Hyperplasic Devices Market - By Procedure Type
1.3.3 North America Benign Prostatic Hyperplasic Devices Market - By End User
1.3.4 North America Benign Prostatic Hyperplasic Devices Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Benign Prostatic Hyperplasic Devices Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. North America Benign Prostatic Hyperplasic Devices Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Prevalence of Benign Prostatic Hyperplasia along with Growing Risk Factors
5.1.2 Increasing Investments, Funds, and Grants for Research in BPH Treatment
5.2 Market Restraints
5.2.1 Limited Awareness of Prostate Health Among Men
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Heighten Product Approvals and Launches
5.5 Impact Analysis
6. North America Benign Prostatic Hyperplasic Devices Market Analysis
6.1 North America Benign Prostatic Hyperplasic Devices Market Revenue Forecast and Analysis
7. North America Benign Prostatic Hyperplasic Devices Market - by Product
7.1 North America Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028)
7.2 Resectoscopes
7.2.1 Overview
7.2.2 Resectoscopes: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
7.3 Urology Lasers
7.3.1 Overview
7.3.2 Urology Lasers: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Radiofrequency Ablation Devices
7.4.1 Overview
7.4.2 Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Prostatic Stents
7.5.1 Overview
7.5.2 Prostatic Stents: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Implants
7.6.1 Overview
7.6.2 Implants: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8. North America Benign Prostatic Hyperplasic Devices Market - by Procedure Type
8.1 North America Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028)
8.2 Transurethral Microwave Therapy
8.2.1 Overview
8.2.2 Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8.3 Transurethral Resection of the Prostate
8.3.1 Overview
8.3.2 Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Transurethral Needle Ablation of the Prostate
8.4.1 Overview
8.4.2 Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Laser Surgery
8.5.1 Overview
8.5.2 Laser Surgery: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8.6 UroLift Surgery
8.6.1 Overview
8.6.2 UroLift Surgery: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Benign Prostatic Hyperplasic Devices Market - by End User
9.1 Overview
9.2 North America Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. North America Benign Prostatic Hyperplasic Devices Market - by Country Analysis
10.1 Overview
10.1.1 North America: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2 North America: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
10.1.3 North America: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
10.1.4 North America: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
10.1.5 North America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.1.5.1 US: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.5.1.1 Overview
10.1.5.1.2 US: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.5.1.3 US: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
10.1.5.1.4 US: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
10.1.5.1.5 US: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
10.1.5.2 Canada: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.5.2.1 Overview
10.1.5.2.2 Canada: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.5.2.3 Canada: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
10.1.5.2.4 Canada: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
10.1.5.2.5 Canada: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
10.1.5.3 Mexico: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.5.3.1 Overview
10.1.5.3.2 Mexico: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.5.3.3 Mexico: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
10.1.5.3.4 Mexico: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
10.1.5.3.5 Mexico: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
11. North America Benign Prostatic Hyperplasic Devices Market - Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.3 Organic Growth Strategies
12. Company Profiles
12.1 KARL STORZ SE & Co. KG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Richard Wolf GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Olympus Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Urologix, LLC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Boston Scientific Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Butterfly
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Teleflex Incorporated
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 OmniGuide Holdings, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Convergent Laser Technologies
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 ProArc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms for Benign Prostatic Hyperplasia Devices Market
LIST OF TABLES
Table 1. North America Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 2. North America Benign Prostatic Hyperplasic Devices Market, by Procedure Type- Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
Table 5. US Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. Recent Inorganic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market
Table 14. Recent Organic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market
Table 15. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Benign Prostatic Hyperplasic Devices Market Segmentation
Figure 2. North America Benign Prostatic Hyperplasic Devices Market, By Country
Figure 3. North America Benign Prostatic Hyperplasic Devices Market Overview
Figure 4. Resectoscopes Segment Held Largest Share of Product Segment in Benign Prostatic Hyperplasic Devices Market
Figure 5. The US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America Benign Prostatic Hyperplasic Devices Market, Industry Landscape
Figure 7. North America: PEST Analysis
Figure 8. Experts Opinion
Figure 9. North America Benign Prostatic Hyperplasic Devices Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. North America Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028)
Figure 11. Resectoscopes: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Urology Lasers: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Prostatic Stents: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Implants: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028)
Figure 17. Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Laser Surgery: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. UroLift Surgery: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028)
Figure 24. Hospitals Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Clinics Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Benign Prostatic Hyperplasic Devices Market, by Key Country - Revenue (2022) (US$ Million)
Figure 29. North America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. North America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
Figure 31. US: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Canada: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Mexico: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security